Abstract
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – New research on Oncology - Ovarian Can cer is the subject of a report.According to news reporting originating from Rom e, Italy, by NewsRx correspondents, research stated, “Most patients with ovarian cancer relapse within 2 years.Prospective randomized trials, such as DESKTOP I II and SOC-I, have shown the role of secondary cytoreduction in improving oncolo gical outcomes in selected patients, when complete tumor resection is achieved.”